<DOC>
	<DOCNO>NCT01504620</DOCNO>
	<brief_summary>The goal single-center , comparative , open label , in-vitro diagnostic device performance evaluation investigate performance two sanofi-aventis BGMSs ( BGStar® iBGStar® ) regard system accuracy ( Polaris ) , precision Hct influence ( Helios ) .</brief_summary>
	<brief_title>Performance Evaluation Blood Glucose Monitoring Systems</brief_title>
	<detailed_description>The main study ( Polaris ) investigate blood glucose measure accuracy intra-assay precision substudy ( Helios ) investigate potential haematocrit interference sanofi-aventis BGMSs BGStar® iBGStar® partly competitor BGMSs accord ISO 15197 [ 1 ] TNO 2001 Quality Guideline [ 2 ] , respectively . The primary objective system accuracy evaluation identify number blood glucose reading sanofi-aventis device within ISO 15197 area acceptable accuracy ± 20 % [ DEV % ] blood sample glucose concentration &gt; 75 mg/dL ( 4.2 mmol/L ) within ISO 15197 area acceptable accuracy ± 15 mg/dL ( ± 0.83 mmol/L ) blood sample glucose concentration &lt; 75 mg/dL ( 4.2 mmol/L ) compare StatStrip® Connectivity reference method . The primary objective haematocrit interference evaluation demonstrate BGStar® iBGStar® device meet Hct interference requirement accord TNO 2001 Quality Guideline use measure BG venous whole blood compare venous plasma reference method ( YSI 2300 STAT Plus™ ) Hct level 35 - 55 % term : ( 1 ) mean deviation exceed ± 10 % [ DEV % ] hyperglycaemic glucose concentration ( 150 - 180 , 250 - 280 , 320 - 350 mg/dL ) ( 2 ) mean deviation exceed ± 18 mg/dL ( 1.0 mmol/L ) [ DEVtotal ] hypo- normoglycaemic glucose value ( 50 - 60 , 100 - 120 mg/dL ) compare reference method Hct level 35 - 55 % .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>healthy subject patient type 1 type 2 diabetes screen glucose level fall require glucose range screen hematocrit value 36 % 55 % history hypotension blood draw intake drug know interfere blood glucose reading biochemical safety parameter outside reference range Hb &lt; 11 g/dL lack compliance history frequent hypoglycemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>diabetes mellitus</keyword>
	<keyword>blood glucose self-assessment</keyword>
	<keyword>Accuracy</keyword>
	<keyword>Intra-Assay precision</keyword>
	<keyword>Hematocrit interference</keyword>
</DOC>